374 related articles for article (PubMed ID: 14577584)
1. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
[TBL] [Abstract][Full Text] [Related]
3. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
4. P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women.
Nagpal JK; Sahni S; Das BR
Eur J Clin Invest; 2002 Dec; 32(12):943-8. PubMed ID: 12534455
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India.
Nagpal JK; Patnaik S; Das BR
Int J Cancer; 2002 Feb; 97(5):649-53. PubMed ID: 11807792
[TBL] [Abstract][Full Text] [Related]
6. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
7. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN
Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578
[TBL] [Abstract][Full Text] [Related]
10. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
[TBL] [Abstract][Full Text] [Related]
11. p53 polymorphism and human papillomavirus infection in Hong Kong women with cervical cancer.
Wong YF; Chung TK; Cheung TH; Nobori T; Hampton GM; Wang VW; Li YF; Chang AM
Gynecol Obstet Invest; 2000; 50(1):60-3. PubMed ID: 10895031
[TBL] [Abstract][Full Text] [Related]
12. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer.
Summersgill KF; Smith EM; Kirchner HL; Haugen TH; Turek LP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Sep; 90(3):334-9. PubMed ID: 10982955
[TBL] [Abstract][Full Text] [Related]
13. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
[TBL] [Abstract][Full Text] [Related]
14. Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women.
Bhattacharya P; Duttagupta C; Sengupta S
Cancer Lett; 2002 Dec; 188(1-2):207-11. PubMed ID: 12406566
[TBL] [Abstract][Full Text] [Related]
15. Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
Tachezy R; Mikysková I; Saláková M; Van Ranst M
Hum Genet; 1999 Dec; 105(6):564-6. PubMed ID: 10647890
[TBL] [Abstract][Full Text] [Related]
16. The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.
Assoumou SZ; Boumba AL; Ndjoyi-Mbiguino A; Khattabi A; Ennaji MM
Med Oncol; 2015 Jan; 32(1):281. PubMed ID: 25502079
[TBL] [Abstract][Full Text] [Related]
17. TP53 polymorphism, HPV infection, and risk of cervical cancer.
Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
[TBL] [Abstract][Full Text] [Related]
18. p53 polymorphism in human papillomavirus-associated esophageal cancer.
Kawaguchi H; Ohno S; Araki K; Miyazaki M; Saeki H; Watanabe M; Tanaka S; Sugimachi K
Cancer Res; 2000 Jun; 60(11):2753-5. PubMed ID: 10850407
[TBL] [Abstract][Full Text] [Related]
19. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
[TBL] [Abstract][Full Text] [Related]
20. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
